Edit |   |
---|---|
Antigenic Specificity | CEACAM5, Human (Labetuzumab biosimilar) |
Clone | Labetuzumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CEACAM5 Recombinant Antibody. Labetuzumab (marketed under the trade name CEA-CIDE) is a humanized IgG1 monoclonal antibody for the treatment of colorectal cancer. It selectively binds to carcinoembryonic cell adhesion molecule 5. |
Immunogen | n/a |
Other Names | Anti-CEACAM5 Recombinant Antibody, Research Grade Labetuzumab, Anti-Human CEACAM5 Recombinant Antibody, hMN14, Antibody Drug Analogues, Monoclonal Antibody, YR1027, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 219649-07-7 |
Catalog # | YR1027 |
Price | please inquire |
Order / More Info | CEACAM5, Human (Labetuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |